As the NKG2D signaling pathway continues to be investigated, we hope to elucidate its complex mechanisms in various diseases, thereby offering new perspectives for the treatment of tumors, metabolic disorders and inflammatory diseases. This evidence concerns the gene KLRK1 and metabolic disease.